Follow The Filings

IMUX Immunic Inc.

Health Care, filed as IMMUNIC INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q2 David Witzke sold out of Immunic.

Who owns IMUX

Sorted by value, long equity only, as of 2026 Q2.

History
David Witzke, Avidity Partners Management exited 2026 Q2 Last 2026 Q1 1.5% Exit −1.46% 669,941 $6.4M History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
DEF 14A Period Jun 29, 2026 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Forms 3, 4 and 5 from EDGAR, 5 rows shown

Filed Form Detail Links
4 Period Sep 16, 2026 (2 forms) Filing Doc
4 Period Aug 6, 2026 Filing Doc
4 Period Jul 5, 2026 (5 forms) Filing Doc
4 Period Jun 29, 2026 (10 forms) Filing Doc
4 Period May 22, 2026 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$93.61M -$100.51M -$97.17M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $52.53M $39.33M $22.87M
Total non-current assets * $1.76M $1.54M $1.18M
Total assets $54.3M $40.87M $24.05M
Total current liabilities $24.73M $22.18M $30.62M
Total non-current liabilities $639,000 $264,000 $107,000
Total equity $28.93M $18.43M -$6.67M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$70.83M -$84.77M -$85.81M
Cash from investing $9.46M -$0.264M -$0.161M
Cash from financing $1.03M $74.54M $65.58M
Net change in cash -$60.07M -$11.01M -$20.18M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.